OpenVSafe by OpenVAERS
Search V-safe

BFK-10068-16027

3 vaccinations 2 coded responses 12 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
941 / CA
Registered
2021-03-21
Relationship
Self
Race
Other
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-25
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-18
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-21
    Registered in v-safe
  4. 2021-03-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  5. 2021-03-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-03-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-03-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Fatigue or tiredness
    Adult check-in
  8. 2021-03-27
    Health check-in — day 7, dose 2
    Feeling: Poor · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-03-27
    Report sent to call center — day 7, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-04-01
    Health check-in — day 14, dose 2
    Feeling: Poor
    Adult check-in
  11. 2021-04-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-15
    Health check-in — day 28, dose 2
    Feeling: Poor
    Adult check-in
  13. 2021-04-22
    Survey response — day 35, dose 2
    MedDRA: Cough, Headache, Nasopharyngitis, Oropharyngeal pain, Sinus congestion, Sneezing — Feeling: Fair
    Free text: Head cold symptoms: sinus congestion, dry cough, headache, sneezing, sore throat.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-06-17
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-09-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-01-04
    Dose 3 — Pfizer-BioNTech
  17. 2022-03-20
    Survey response — 12 months, dose 2
    MedDRA: Arthralgia, Cough, Fatigue, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Fatigue; joint aches; runny nose; congestion; cough
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-02-25Pfizer-BioNTech
22021-03-18Pfizer-BioNTech
32022-01-04Pfizer-BioNTech No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 7 — day 35, dose 2

2021-04-22

Symptoms: Head cold symptoms: sinus congestion, dry cough, headache, sneezing, sore throat.

Release 11 — 12 months, dose 2

2022-03-20

Symptoms: Fatigue; joint aches; runny nose; congestion; cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia · · ✓
SDCough ✓ ✓ ✓
SDFatigue · · ✓
SDHeadache ✓ ✓ ✓
SDNasopharyngitis ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDSinus congestion ✓ ✓ ✓
SDSneezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release